Ryuji Morizane

5.6k total citations · 3 hit papers
49 papers, 3.6k citations indexed

About

Ryuji Morizane is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Ryuji Morizane has authored 49 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Molecular Biology, 19 papers in Pulmonary and Respiratory Medicine and 14 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Ryuji Morizane's work include Renal and related cancers (39 papers), Pluripotent Stem Cells Research (22 papers) and Renal cell carcinoma treatment (18 papers). Ryuji Morizane is often cited by papers focused on Renal and related cancers (39 papers), Pluripotent Stem Cells Research (22 papers) and Renal cell carcinoma treatment (18 papers). Ryuji Morizane collaborates with scholars based in United States, Japan and France. Ryuji Morizane's co-authors include Joseph V. Bonventre, M. Todd Valerius, Albert Q. Lam, Benjamin Freedman, Navin Gupta, Seiji Kishi, Tomoya Miyoshi, Jennifer A. Lewis, Katharina T. Kroll and Thomas C. Ferrante and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

Ryuji Morizane

49 papers receiving 3.6k citations

Hit Papers

Flow-enhanced vascularization and maturation of kidney ... 2015 2026 2018 2022 2019 2015 2015 200 400 600

Peers

Ryuji Morizane
Pei Xuan Er Australia
Matthias S. Roost Netherlands
Valeria V. Orlova Netherlands
R. Grant Rowe United States
Su‐Li Cheng United States
Purushothama Rao Tata United States
Ryuji Morizane
Citations per year, relative to Ryuji Morizane Ryuji Morizane (= 1×) peers Minoru Takasato

Countries citing papers authored by Ryuji Morizane

Since Specialization
Citations

This map shows the geographic impact of Ryuji Morizane's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ryuji Morizane with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ryuji Morizane more than expected).

Fields of papers citing papers by Ryuji Morizane

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ryuji Morizane. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ryuji Morizane. The network helps show where Ryuji Morizane may publish in the future.

Co-authorship network of co-authors of Ryuji Morizane

This figure shows the co-authorship network connecting the top 25 collaborators of Ryuji Morizane. A scholar is included among the top collaborators of Ryuji Morizane based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ryuji Morizane. Ryuji Morizane is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Morizane, Ryuji & Mart M. Lamers. (2025). Organoids in disease modeling and regenerative medicine. Cellular and Molecular Life Sciences. 82(1). 169–169. 2 indexed citations
2.
Tabibzadeh, Nahid & Ryuji Morizane. (2024). Advancements in therapeutic development: kidney organoids and organs on a chip. Kidney International. 105(4). 702–708. 10 indexed citations
3.
Borges, Thiago J., Sebastien G. M. Uzel, Ivy A. Rosales, et al.. (2024). Exploring immune response toward transplanted human kidney tissues assembled from organoid building blocks. iScience. 27(10). 110957–110957. 4 indexed citations
4.
Susa, Koichiro, Kenichi Kobayashi, Pierre Galichon, et al.. (2023). ATP/ADP biosensor organoids for drug nephrotoxicity assessment. Frontiers in Cell and Developmental Biology. 11. 1138504–1138504. 31 indexed citations
5.
Morizane, Ryuji, et al.. (2023). Strategies for Improving Vascularization in Kidney Organoids: A Review of Current Trends. Biology. 12(4). 503–503. 12 indexed citations
6.
Ruiz‐Babot, Gerard, Fernando Abollo‐Jiménez, Diana L. Carlone, et al.. (2023). Generation of glucocorticoid-producing cells derived from human pluripotent stem cells. Cell Reports Methods. 3(11). 100627–100627. 8 indexed citations
7.
Tekgüç, Murat, Sebastien G. M. Uzel, Navin Gupta, et al.. (2022). Kidney organoids: a pioneering model for kidney diseases. Translational research. 250. 1–17. 29 indexed citations
8.
Gupta, Navin, Ken Hiratsuka, Kenichi Kobayashi, et al.. (2022). Live functional assays reveal longitudinal maturation of transepithelial transport in kidney organoids. Frontiers in Cell and Developmental Biology. 10. 978888–978888. 19 indexed citations
9.
Morizane, Ryuji, et al.. (2021). Bioengineered Kidney Models: Methods and Functional Assessments. Function. 2(4). zqab026–zqab026. 12 indexed citations
10.
Gupta, Navin & Ryuji Morizane. (2021). Kidney development to kidney organoids and back again. Seminars in Cell and Developmental Biology. 127. 68–76. 11 indexed citations
11.
Jung, Youngsook L., Tomoya Miyoshi, Dhawal Jain, et al.. (2020). Epigenetic transcriptional reprogramming by WT1 mediates a repair response during podocyte injury. Science Advances. 6(30). eabb5460–eabb5460. 25 indexed citations
12.
Gupta, Navin, et al.. (2020). 3D kidney organoids for bench-to-bedside translation. Journal of Molecular Medicine. 99(4). 477–487. 21 indexed citations
13.
Kishi, Seiji, Craig R. Brooks, Kensei Taguchi, et al.. (2019). Proximal tubule ATR regulates DNA repair to prevent maladaptive renal injury responses. Journal of Clinical Investigation. 129(11). 4797–4816. 88 indexed citations
14.
Homan, Kimberly A., Navin Gupta, Katharina T. Kroll, et al.. (2019). Flow-enhanced vascularization and maturation of kidney organoids in vitro. Nature Methods. 16(3). 255–262. 670 indexed citations breakdown →
15.
Morizane, Ryuji. (2019). Modelling diabetic vasculopathy with human vessel organoids. Nature Reviews Nephrology. 15(5). 258–260. 8 indexed citations
16.
Gupta, Navin, Koichiro Susa, & Ryuji Morizane. (2017). Regenerative Medicine, Disease Modelling, and Drug Discovery in Human Pluripotent Stem Cell-Derived Kidney Tissue. 57–67. 2 indexed citations
17.
Morizane, Ryuji, Shizuka Fujii, Toshiaki Monkawa, et al.. (2015). miR-363 induces transdifferentiation of human kidney tubular cells to mesenchymal phenotype. Clinical and Experimental Nephrology. 20(3). 394–401. 9 indexed citations
18.
Freedman, Benjamin, Craig R. Brooks, Albert Q. Lam, et al.. (2015). Modelling kidney disease with CRISPR-mutant kidney organoids derived from human pluripotent epiblast spheroids. Nature Communications. 6(1). 8715–8715. 567 indexed citations breakdown →
19.
Yamaguchi, Shintaro, Kenichi Yamahara, Koichiro Homma, et al.. (2011). The role of microRNA-145 in human embryonic stem cell differentiation into vascular cells. Atherosclerosis. 219(2). 468–474. 53 indexed citations
20.
Morizane, Ryuji, Hiroyuki Sasamura, Hitoshi Minakuchi, et al.. (2008). A case of atypical POEMS syndrome without polyneuropathy. European Journal Of Haematology. 80(5). 452–455. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026